Can Huang

748 total citations
23 papers, 559 citations indexed

About

Can Huang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Can Huang has authored 23 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Can Huang's work include Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (4 papers) and RNA modifications and cancer (4 papers). Can Huang is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (4 papers) and RNA modifications and cancer (4 papers). Can Huang collaborates with scholars based in China, France and United States. Can Huang's co-authors include Juan Iovanna, Patricia Santofimia‐Castaño, Yi Xia, Wenjun Lan, Ling Peng, José L. Neira, Ming Shen, Xiangyu Zhang, Yourong Duan and Ying Sun and has published in prestigious journals such as Journal of Clinical Investigation, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Can Huang

19 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Can Huang China 13 323 117 112 109 101 23 559
Suoyuan Li China 11 324 1.0× 73 0.6× 86 0.8× 195 1.8× 69 0.7× 22 556
Hegen Li China 14 256 0.8× 94 0.8× 159 1.4× 109 1.0× 190 1.9× 44 653
Magdalena Rudzińska Poland 15 294 0.9× 114 1.0× 59 0.5× 121 1.1× 123 1.2× 26 602
Minhee Kim South Korea 9 294 0.9× 58 0.5× 77 0.7× 154 1.4× 90 0.9× 14 460
Rongjian Su China 16 410 1.3× 101 0.9× 47 0.4× 101 0.9× 125 1.2× 27 654
Tao Tan China 13 232 0.7× 72 0.6× 89 0.8× 65 0.6× 176 1.7× 37 645
Wenhua Zhan China 14 352 1.1× 83 0.7× 117 1.0× 175 1.6× 186 1.8× 41 720
Joshua Prey United States 13 242 0.7× 142 1.2× 90 0.8× 43 0.4× 113 1.1× 22 550

Countries citing papers authored by Can Huang

Since Specialization
Citations

This map shows the geographic impact of Can Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Huang more than expected).

Fields of papers citing papers by Can Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Huang. The network helps show where Can Huang may publish in the future.

Co-authorship network of co-authors of Can Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Can Huang. A scholar is included among the top collaborators of Can Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can Huang. Can Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yanxia, Aoyang Yü, Yu Rao, et al.. (2025). Single-cell transcriptomics identifies PDIA4 as a marker of progression and therapeutic vulnerability in multiple myeloma. Journal of Translational Medicine. 23(1). 1136–1136.
2.
Huang, Can, Qingping Li, Biao Wang, et al.. (2024). Accumulation of polyunsaturated lipids fuels ferroptosis to promote liver failure after extended hepatectomy in mice. Free Radical Research. 58(11). 733–747.
3.
Huang, Jing, et al.. (2024). Comprehensive analysis reveals the prognostic and immunogenic characteristics of DNA methylation regulators in lung adenocarcinoma. Respiratory Research. 25(1). 74–74. 1 indexed citations
4.
Dong, Kuiran, Kai Li, Jiangbin Liu, et al.. (2023). Extracranial Germ Cell Tumors in Children: Ten Years of Experience in Three Children’s Medical Centers in Shanghai. Cancers. 15(22). 5412–5412.
5.
Santofimia‐Castaño, Patricia, Can Huang, Xi Liu, et al.. (2022). NUPR1 protects against hyperPARylation-dependent cell death. Communications Biology. 5(1). 732–732. 13 indexed citations
6.
Cheng, Huiying, Can Huang, Xiang Gu, et al.. (2021). Bacterial Lipopolysaccharide Augmented Malignant Transformation and Promoted the Stemness in Prostate Cancer Epithelial Cells. Journal of Inflammation Research. Volume 14. 5849–5862. 6 indexed citations
7.
Huang, Can, Juan Iovanna, & Patricia Santofimia‐Castaño. (2021). Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer. International Journal of Molecular Sciences. 22(9). 4970–4970. 38 indexed citations
8.
Huang, Can, Patricia Santofimia‐Castaño, Xi Liu, et al.. (2021). NUPR1 inhibitor ZZW-115 induces ferroptosis in a mitochondria-dependent manner. Cell Death Discovery. 7(1). 269–269. 47 indexed citations
9.
Lan, Wenjun, Patricia Santofimia‐Castaño, Yi Xia, et al.. (2020). ZZW-115–dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents. JCI Insight. 5(18). 33 indexed citations
10.
Lan, Wenjun, Patricia Santofimia‐Castaño, Yi Xia, et al.. (2020). Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma. Cancer Letters. 486. 8–17. 27 indexed citations
11.
Jiang, Jiajia, et al.. (2020). Tumor Suppressive Maspin-Sensitized Prostate Cancer to Drug Treatment Through Negative Regulating Androgen Receptor Expression. Frontiers in Cell and Developmental Biology. 8. 573820–573820. 8 indexed citations
12.
Huang, Can, et al.. (2020). Therapeutic potential of targeting MYCN. Medicine. 99(25). e20853–e20853. 4 indexed citations
13.
Huang, Can, et al.. (2020). Inducing ferroptosis by the NUPR1 inhibitor ZZW115 to kill pancreatic cancer cells. Pancreatology. 20. S122–S122. 1 indexed citations
14.
Santofimia‐Castaño, Patricia, Yi Xia, Wenjun Lan, et al.. (2019). Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis. Journal of Clinical Investigation. 129(6). 2500–2513. 79 indexed citations
15.
Huang, Can, et al.. (2019). Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma. Cancers. 11(12). 1869–1869. 34 indexed citations
16.
Ding, Li, Qi Wang, Ming Shen, et al.. (2017). Thermoresponsive nanocomposite gel for local drug delivery to suppress the growth of glioma by inducing autophagy. Autophagy. 13(7). 1176–1190. 71 indexed citations
17.
Sun, Ying, Yunkai Zhu, Can Huang, et al.. (2015). Magnetite loaded Polypeptide‐PLGA multifunctional microbubbles for dual‐mode US/MR imaging. Contrast Media & Molecular Imaging. 11(2). 146–153. 14 indexed citations
18.
Li, Jianyun, et al.. (2015). [Myeloid sarcoma with acute promyelocytic leukemia:two cases report].. PubMed. 36(5). 438–40. 1 indexed citations
19.
Huang, Can, et al.. (2015). Altered Cell Cycle Arrest by Multifunctional Drug-Loaded Enzymatically-Triggered Nanoparticles. ACS Applied Materials & Interfaces. 8(2). 1360–1370. 23 indexed citations
20.
He, Zelai, Jingwen Huang, Yuanyuan Xu, et al.. (2015). Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. Oncotarget. 6(39). 42150–42168. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026